loading...| Preferred Name |
tapentadol hydrochloride ER |
|
| Synonyms |
CG5503 ER |
|
| Definitions |
An orally active, extended-release preparation of the hydrochloride salt of tapentadol with analgesic activity. Tapentadol is a synthetic, centrally acting analgesic with a dual mechanism of action involving mu-opioid receptor agonism and norepinephrine reuptake inhibition. This agent may be effective in the management of pain, cancer-related and other. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C68922" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C68922" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000552929 |
|
| altLabel |
CG5503 ER |
|
| cui |
C2348651 C2710874 |
|
| DATE FIRST PUBLISHED |
2007-05-23 |
|
| Date last modified |
2007-10-22 |
|
| definition |
An orally active, extended-release preparation of the hydrochloride salt of tapentadol with analgesic activity. Tapentadol is a synthetic, centrally acting analgesic with a dual mechanism of action involving mu-opioid receptor agonism and norepinephrine reuptake inhibition. This agent may be effective in the management of pain, cancer-related and other. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C68922" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C68922" NCI Thesaurus) |
|
| NCI ID |
C68922 |
|
| notation |
CDR0000552929 |
|
| ORIG STY |
Drug/agent |
|
| prefLabel |
tapentadol hydrochloride ER |
|
| tui |
T109 T121 |